21 related articles for article (PubMed ID: 4801079)
1. Fatality associated with benzedrine ingestion; a case report.
HARVEY JK; TODD CW; HOWARD JW
Del State Med J; 1949 Jul; 21(7):111-5. PubMed ID: 18133760
[No Abstract] [Full Text] [Related]
2. Modification by methyltyrosine methylester (H 44-68) of the amphetamine-induced toxicity and brain catecholamine changes in developing mice.
Alhava E
Acta Pharmacol Toxicol (Copenh); 1973; 32(1):119-28. PubMed ID: 4741031
[No Abstract] [Full Text] [Related]
3. Age and brain catecholamine content as factors influencing amphetamine toxicity in mice.
Alhava E; Klinge E
Acta Pharmacol Toxicol (Copenh); 1972; 31(5):401-11. PubMed ID: 4678823
[No Abstract] [Full Text] [Related]
4. Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
Lal H; Colpaert FC; Laduron P
Eur J Pharmacol; 1975 Jan; 30(1):113-6. PubMed ID: 1168136
[TBL] [Abstract][Full Text] [Related]
5. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
Von Voigtlander PF; Moore KE
Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
[No Abstract] [Full Text] [Related]
6. Effect of diethyldithiocarbamate on the toxicity of amphetamine in aggregated mice.
Przegalinski E; Kleinrok Z
Psychopharmacologia; 1970; 16(5):409-18. PubMed ID: 5435877
[No Abstract] [Full Text] [Related]
7. Aminergic neurons and substitute transmitters in brain.
Kopin IJ
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():207-15. PubMed ID: 4403652
[No Abstract] [Full Text] [Related]
8. Factors affecting amphetamine toxicity in aggregated mice.
Sethy VH; Sheth UK
Indian J Med Sci; 1968 Jun; 22(6):364-79. PubMed ID: 4880135
[No Abstract] [Full Text] [Related]
9. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
Alhava E
Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
[No Abstract] [Full Text] [Related]
10. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
Pletscher A; Bartholini G; Gey KF; Jenni A
Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
